DRK
Sphere 3D Corp.
There isn't enough reported data to score DRK yet.
MSFT
Microsoft Corporation
MSFT's fundamentals are strong and it looks cheap: trading at 27x earnings, below its usual 34x. Analysts expect strong earnings growth.
DRK Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Weak | |
| Unavailable |
DRK's revenue is currently stable, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
MSFT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Healthy | |
| Strong |
MSFT's revenue, profitability, cash flow and balance sheet are all currently healthy.
DRK PE Valuation
DRK has no meaningful PE right now: it lost money over the past year.
MSFT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 25x | $523 | — |
| Cheap | 27x | $525 | +0.4% |
| Current | 27x | $523 | — |
| Fair | 34x | $652 | +25% |
| Expensive | 37x | $711 | +36% |
Historical ranges are pointers, not guarantees.
MSFT's PE is in its cheap range at 27x. If earnings grow as analysts expect, today's price would be 25x next year's earnings.
DRK Forward outlook
There aren't enough analyst estimates for DRK to show an outlook.
MSFT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Stable | |
| Moderate | |
| High |
Analysts expect strong earnings and revenue growth for MSFT, with profitability holding steady.
DRK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$7.78 | -$0.53 |
| Q2 2026 | -$8.63 | -$2.93 |
| Q1 2026 | -$5.35 | -$0.05 |
| Q4 2025 | -$7.37 | -$2.57 |
| Q3 2025 | -$7.25 | +$3.80 |
| Q2 2025 | -$5.70 | +$10.40 |
| Q1 2025 | -$5.30 | +$16.20 |
| Q4 2024 | -$4.80 | +$17.50 |
DRK is still losing money, but far less than before: $7.78 per share over the past year, against $22.30 at its worst in late 2023.
MSFT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $20.79 | +8.6% |
| Q3 2026 | $19.15 | +36% |
| Q2 2026 | $17.95 | +32% |
| Q1 2026 | $16.80 | +30% |
| Q4 2025 | $15.99 | +29% |
| Q3 2025 | $14.06 | +16% |
| Q2 2025 | $13.64 | +16% |
| Q1 2025 | $12.93 | +12% |
| Q4 2024 | $12.41 | +12% |
MSFT has the edge over DRK on earnings quality, reporting a profit while its opponent remains loss making.
DRK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3M | +16% |
| Q2 2026 | $2.5M | -19% |
| Q1 2026 | $1.9M | -32% |
| Q4 2025 | $2.7M | +3.1% |
| Q3 2025 | $2.6M | +11% |
| Q2 2025 | $3M | -35% |
| Q1 2025 | $2.8M | -59% |
| Q4 2024 | $2.6M | -66% |
DRK's revenue is recovering but still below its 2023 peak: $3M last quarter, up 16% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -191% | -37 points |
| Q2 2026 | -564% | -477 points |
| Q1 2026 | -216% | -31 points |
| Q4 2025 | -373% | -44 points |
| Q3 2025 | -154% | +65 points |
| Q2 2025 | -87% | +35 points |
| Q1 2025 | -184% | -157 points |
| Q4 2024 | -329% | -132 points |
DRK's operating margin was −191% last quarter, down 37 points from the same quarter a year ago.
MSFT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $92.3B | +19% |
| Q2 2026 | $90B | +18% |
| Q1 2026 | $82.9B | +18% |
| Q4 2025 | $81.3B | +17% |
| Q3 2025 | $77.7B | +18% |
| Q2 2025 | $76.4B | +18% |
| Q1 2025 | $70.1B | +13% |
| Q4 2024 | $69.6B | +12% |
MSFT has the edge over DRK on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 50% | +0.9 points |
| Q2 2026 | 45% | +0.2 points |
| Q1 2026 | 46% | +0.7 points |
| Q4 2025 | 47% | +1.6 points |
| Q3 2025 | 49% | +2.3 points |
| Q2 2025 | 45% | +1.8 points |
| Q1 2025 | 46% | +1.1 points |
| Q4 2024 | 45% | +1.9 points |
MSFT has the edge over DRK on profitability, with a higher operating margin.
DRK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$4.5M | +$1.3M |
| Q2 2026 | -$5.3M | +$745K |
| Q1 2026 | -$3.7M | +$1.4M |
| Q4 2025 | -$6.7M | -$904K |
| Q3 2025 | -$5.7M | -$1.4M |
| Q2 2025 | -$6.1M | -$2.8M |
| Q1 2025 | -$5.1M | -$5M |
| Q4 2024 | -$5.8M | -$5.3M |
DRK has burned cash in almost every quarter: −$20M over the past year, against −$23M the year before.
MSFT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $18.6B | -27% |
| Q2 2026 | $19.6B | -23% |
| Q1 2026 | $15.8B | -22% |
| Q4 2025 | $5.9B | -9.3% |
| Q3 2025 | $25.7B | +33% |
| Q2 2025 | $25.6B | +9.6% |
| Q1 2025 | $20.3B | -3.2% |
| Q4 2024 | $6.5B | -29% |
MSFT has the edge over DRK on cash generation, producing positive trailing cash flow while its opponent burns cash.
DRK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +71% | +3.7M shares |
| 1 year | +219% | +6.1M shares |
| 3 years | +8805% | +8.7M shares |
DRK has 9M diluted shares, up 219% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
MSFT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -7M shares |
| 1 year | -0.3% | -20M shares |
| 3 years | -0.2% | -16M shares |
| 5 years | -1.6% | -121M shares |
| Available history | -3.2% | -245M shares |
MSFT has the edge over DRK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $4.4B |
| Q2 2026 | $4.6B |
| Q1 2026 | $4.6B |
| Q4 2025 | $7.4B |
| Q3 2025 | $5.7B |
| Q2 2025 | $4.5B |
| Q1 2025 | $4.8B |
| Q4 2024 | $5B |
MSFT spent $21B buying back its own shares over the past year, up 5.2% from the year before.
DRK Net Leverage
DRK's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
MSFT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | 0.1x | Very low |
MSFT's net debt is less than a year of its operating earnings (EBITDA).
DRK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.7 | Neutral |
| Stochastic | 5.2 | Oversold |
DRK's weekly RSI is 42 (neutral) and its Stochastic is 5 (oversold).
MSFT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 62.1 | Neutral |
| Stochastic | 68.0 | Neutral |
MSFT's weekly RSI is 62 (neutral) and its Stochastic is 68 (neutral).
DRK PE vs Technology Sector
DRK has no meaningful PE right now: it lost money over the past year.
MSFT PE vs Technology Sector
| Metric | MSFT | Sector median | Relative |
|---|---|---|---|
| PE | 27x | 28x | 2% below |
| PE % | 16 | 35 | 19 pts below |
MSFT is trading at 27x earnings, in line with the Technology sector's median of 28x.
DRK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.18 | 24% below |
| 20 week MA | $2.26 | 27% below |
| 50 week MA | $2.34 | 29% below |
| 100 week MA | $4.61 | 64% below |
| 200 week MA | $10.8 | 85% below |
DRK is in a downtrend: it's below all five of its weekly moving averages, and 85% below its 200-week average.
MSFT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $524.7 | 0.3% below |
| 20 week MA | $484.8 | 7.9% above |
| 50 week MA | $446.9 | 17% above |
| 100 week MA | $453.8 | 15% above |
| 200 week MA | $411.5 | 27% above |
MSFT has the edge over DRK on trend strength, trading above more of its moving averages.
DRK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.2 | $109.2 | +113% |
| 2021 | $109.2 | $247.8 | +127% |
| 2022 | $247.8 | $21.0 | -92% |
| 2023 | $21.0 | $33.2 | +58% |
| 2024 | $33.2 | $9.61 | -71% |
| 2025 | $9.61 | $3.61 | -62% |
| 2026 YTD | $3.61 | $1.66 | -54% |
DRK's yearly returns have swung widely, from +127% in 2021 to −92% in 2022. It's down 54% so far in 2026.
MSFT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $159.0 | $222.8 | +40% |
| 2021 | $222.8 | $334.7 | +50% |
| 2022 | $334.7 | $238.7 | -29% |
| 2023 | $238.7 | $376.0 | +58% |
| 2024 | $376.0 | $430.5 | +14% |
| 2025 | $430.5 | $487.7 | +13% |
| 2026 YTD | $487.7 | $523.0 | +7.2% |
MSFT has the edge over DRK on returns for 2026, with the stronger performance.